[ad_1]
NEW YORK (Reuters Health) – A drug widely used to treat type 2 diabetes has proven effective in the treatment of heart disease, according to a recent Japanese study.
The study was conducted by researchers from the Kyoto University Hospital in Japan and published their findings on Tuesday in the latest issue of the scientific publication Circulation.
The team studied the efficacy of dapagliflozin, a drug used to treat type 2 diabetes, and was approved by the US Food and Drug Administration and the European Medicines Agency to control blood sugar levels .
In an experiment conducted in 33 countries around the world, involving more than 17,000 patients with type 2 diabetes and cardiovascular disease, the team administered dabagliphlozin to half of the participants. while the other half received a placebo.
The team followed participants up to 4 years and during the follow-up period, 13% of participants had heart failure.
The researchers found that patients taking dabagliphlozine had a risk of death from heart disease and heart failure 41-45% less than placebo.
They also found that people who took the medication had reduced their chances of hospitalization due to heart failure or other heart disease at 38%.
Dr. Eri Kato, team leader, said that Dabagliphlozine reduced people's access to hospitals because of heart failure, whether or not they had heart failure at home. beginning of the study.
"The use of the drug may be beneficial for a very large number of people with type 2 diabetes at risk for heart disease," he added.
Heart failure patients usually lose their ability to pump blood properly and the body 's organs do not receive an abundant supply of blood and oxygen, resulting in a constant feeling of exhaustion and fatigue.
In addition to feeling exhausted, tired or swollen, the symptoms also include shortness of breath when climbing stairs, for example a reduced ability to exert effort or a general state of weakness.
According to the World Health Organization (WHO), cardiovascular disease is the leading cause of death in the world, with more deaths than any other cause of death.
About 17.3 million people die each year from heart disease, which is 30% of the total number of deaths worldwide. By 2030, 23 million people are expected to die of heart disease each year, said WHO.
Source link
